Anatara Lifesciences Ltd

ASX:ANR ISIN:AU000000ANR0

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) is developing therapeutics for gastrointestinal diseases in production animals and humans. Its lead product Detach(R) is a natural plant based product that will help address global concerns around the overuse of antibiotics in production animals that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies. Please see http://www.anataralifesciences.com for further background.

     

News

Anatara Lifesciences Ltd (ASX:ANR) Pork CRC Options Extended by 12 Months

🕔9/13/2017 9:36:01 AM 637

Anatara Lifesciences Limited (ASX:ANR) has today undertaken to extend by 12 months the expiry date of 250,000 Options which Anatara issued to the Pork Cooperative Research Centre in 2015.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) and Zoetis to Negotiate Terms of International Detach(R) Commercial Agreement

🕔8/21/2017 8:55:23 AM 1211

Anatara Lifesciences Ltd (ASX:ANR) is pleased to announce that global animal health company, Zoetis Inc. has exercised its option to negotiate a commercial agreement for the worldwide development, distribution and marketing of Detach(R), with terms to be agreed.

Read Full Article

FINANCE VIDEO: Anatara Lifesciences Ltd (ASX:ANR) Gold Coast Investment Showcase Investor Presentation

🕔6/21/2017 2:07:56 PM 3070

Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation for the Gold Coast Investment Showcase (June 21st & 22nd 2017).

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Wilsons Equity Research Report Issued with Buy Rating

🕔6/8/2017 10:30:52 AM 1696

Wilsons maintain a BUY rating and $1.66 price target. Anatara's recent stock underperformance has simply reflected a slow quarter for news in the lead-up to a significant inflection point in the 2H.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Investor Update and R&D Tax Rebate

🕔6/6/2017 8:24:57 AM 1986

Anatara Lifesciences Ltd (ASX:ANR) is pleased to provide investors with an update on recent progress.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) ABC Video Program - Non-Antibiotic Treatment for Pigs

🕔3/23/2017 6:45:01 PM 2629

An oral drench to protect piglets from gut infection could soon be available to pig farmers. It's been developed by scientists and is made from pineapples - taking antibiotics out of the food chain.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Half Yearly Report and Accounts

🕔2/23/2017 9:20:20 AM 2174

Anatara Lifesciences Ltd (ASX:ANR) is pleased to provide the Company's Half Yearly Report for the period ended 31 December, 2016.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Receives Second Payment for Detach Under The Agreement with Zoetis (NYSE:ZTS)

🕔1/30/2017 10:20:19 AM 2878

Anatara Lifesciences Ltd (ASX:ANR) is pleased to announce that it has received a second payment under the exclusive Evaluation and License Option Agreement with the leading global animal health company Zoetis Inc. (NYSE:ZTS) for Detach(TM), Anatara's non-antibiotic anti-infective product.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Research Report 'A Good Gut Feeling' by NDF Research

🕔1/25/2017 10:24:29 AM 2487

NDF Research yesterday released its initiation report on Anatara Lifesciences Ltd (ASX:ANR). The report provided a valuation at $2.22 per share base case and $5.94 per share optimistic case using a DCF approach, with a target price of $4.00 per share sitting midpoint of their valuation range.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Investor Update

🕔11/22/2016 8:27:13 AM 2079

Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its updated investor presentation.

Read Full Article
###

7,826 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 87) (Last 30 Days: 420) (Since Published: 7826) 

Markets ASX:ANR

Company Data

    Headquarters
  • 433 Logan Road, Stones Corner
    Brisbane, Queensland 4120
    Australia
  • Principal Sector
  • Biotech 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.anataralifesciences.com
  • E:
  • info@anataralifesciences.com

Company Reports

Presentations

Research Report

Social Media